WallStreetZenWallStreetZen

NASDAQ: AXDX
Accelerate Diagnostics Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their AXDX stock forecasts and price targets.

Forecast return on equity

Is AXDX forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is AXDX forecast to generate an efficient return on assets?

AXDX revenue forecast

What is AXDX's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$19.0M+58.28%

AXDX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
AXDX$0.97N/AN/A
TBIO$0.53N/AN/A
INBS$5.52N/AN/A
SSKN$0.50N/AN/A
OSA$0.64$1.50+134.38%Buy

Accelerate Diagnostics Stock Forecast FAQ

What is AXDX's revenue growth forecast for 2024-2024?

(NASDAQ: AXDX) Accelerate Diagnostics's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Accelerate Diagnostics's revenue in 2024 is $12,004,000.

In 2024, AXDX is forecast to generate $276,461,495 in revenue, with the lowest revenue forecast at $276,461,495 and the highest revenue forecast at $276,461,495.

If you're new to stock investing, here's how to buy Accelerate Diagnostics stock.

What is AXDX's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: AXDX) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 9.42%.

What is AXDX's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: AXDX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.